Movement is an essential part of everyday life, from climbing stairs and staying active to simply maintaining independence with age. As people increasingly look for ways to support long-term mobility and resilience, advances in regenerative science are creating new possibilities for bone and joint health. The focus is gradually moving beyond temporary relief and basic nutritional support toward approaches that work with the body’s natural biological processes.
This is where ZyCal Bioceuticals Healthcare Co., Inc. has established its purpose. Led by James J. Scaffidi, D.N.M.c., B.Sc., President & CEO, the company is translating principles rooted in orthopedic biology into accessible approaches for everyday wellness. Its work centers on oral growth-factor complexes and the potential of regenerative nutrition to support bone and cartilage health.
From its foundation in orthopedic research to the development of its Cyplexinol® and Ostinol® platforms, ZyCal’s journey reflects a commitment to bringing scientific discoveries beyond the operating room and into everyday health.
Let’s explore the science, vision, and innovation shaping ZyCal’s approach to the future of bone and joint health!
Where Orthopedic Science Meets Everyday Wellness
The roots of ZyCal can be traced to the orthopedic spine and bone biology community, where surgeons had spent decades studying ways to stimulate skeletal regeneration. Long before nutraceuticals became part of the conversation, medical teams were using bone extracts containing growth factors known as bone morphogenetic proteins, or BMPs, to promote fusion and post-operative healing.
These specialized proteins could activate mesenchymal stem cells and guide them toward becoming bone-forming osteoblasts or cartilage-forming chondrocytes. In complex spinal surgeries and bone grafting procedures, BMP complexes became important tools for supporting skeletal healing and improving patient outcomes.
However, these complexes remained largely confined to surgical environments. They generally had to be implanted directly into the body and were used primarily in applications such as fractures and spinal fusions. This meant that individuals looking for long-term bone and joint support in everyday life could not access the same biological principles used by surgeons.
The founders of ZyCal recognized this gap and began asking whether the regenerative potential of BMP-complexes could be adapted into a natural nutraceutical format that could be taken orally rather than surgically implanted.
That thinking was influenced by earlier scientific breakthroughs. In the mid-1960s, Dr. Marshall Urist published research describing how specific proteins within bone extracts could trigger new bone formation when placed into living tissue. His discovery helped establish the foundation for orthopedic regenerative medicine. Over the following decades, research into BMPs continued to demonstrate their importance in tissue formation and skeletal healing.
ZyCal was born from this scientific history and the belief that the biology behind these discoveries could be explored in a form accessible beyond the surgical environment.
Developing an Oral Growth-Factor Complex
Adapting surgical biology for oral use presented a different challenge. Traditional BMP-complexes used during surgery require precise placement at the site where regeneration is needed. ZyCal sought to create an orally delivered complex that could preserve the natural signaling environment found in bone extract while being suitable for nutritional use.
This work led to the development of Cyplexinol®, a natural complex of bone-derived growth factors that includes BMPs and other proteins associated with skeletal formation. Cyplexinol® is sourced from certified organic bovine bone and processed under controlled conditions designed to maintain the activity of the growth-factor complex. “Cyplexinol® provides active signaling that encourages the body to recruit stem cells and direct them toward skeletal rebuilding.” According to ZyCal, each batch is certified by an independent laboratory to activate stem cells and support the growth of new bone and cartilage tissue.
According to ZyCal, each batch is certified by an independent laboratory to activate stem cells and support the growth of new bone and cartilage tissue.
This approach distinguishes Cyplexinol® from ingredients such as minerals and collagen that primarily provide building blocks for structural support. The company’s approach instead focuses on active biological signaling and pathways associated with bone and cartilage formation.
For ZyCal, the development of Cyplexinol® represents an effort to bring principles that have long been associated with orthopedic regenerative science into the field of everyday bone and joint wellness.
Building the Ostinol® Brand
To bring Cyplexinol® to consumers, ZyCal developed its own product platform, Ostinol® Bone and Cartilage Stimulating Proteins. The brand includes products focused on bone health and joint health, with formulas designed to address different needs.
The bone-health line focuses on bone-building pathways and the body’s ability to activate and transform stem cells into osteoblasts. These cells play an important role in producing new bone tissue, creating the framework to which calcium and other minerals can bind.
The joint-health line combines Cyplexinol® with other nutrients intended to support joint comfort and the body’s ability to regenerate cartilage. The consumer products include formulas for everyday support as well as specialized options for individuals experiencing greater physical strain.
There are products intended for people seeking support for weight-bearing joints, along with higher-dose variations designed for athletes, older adults, or individuals recovering from injury.
While each formula has a specific purpose, they share the same underlying principle: supporting short-term comfort while contributing to long-term structural resilience by activating the body’s natural regenerative processes.
ZyCal has also developed an advanced line of practitioner-only products. These formulas contain higher concentrations of Cyplexinol® and are intended for use under the guidance of healthcare professionals, including integrative physicians, chiropractors, and naturopathic doctors.
This allows practitioners to adjust the level of support over time according to individual needs, creating a more targeted approach to bone and joint health.
Science at the Center
Scientific research remains an important part of ZyCal’s approach. Research involving Cyplexinol® and Ostinol® combines laboratory research, clinical trials, preclinical findings, and real-world experiences.
A double-blind, placebo-controlled clinical study conducted by the University of Memphis examined individuals experiencing knee and hip pain. The study found that Cyplexinol® supplementation reduced pain and stiffness while improving physical function. Participants reported improvements in mobility during everyday activities such as walking and climbing stairs, with effects building over several weeks.
Preclinical studies have also examined BMP-complexes and their ability to generate new bone and cartilage in vivo. In limited, well-controlled extended case studies involving Cyplexinol® for bone health, measurable increases in bone mineral density have been observed. Some users of Cyplexinol® in the form of Ostinol® have also reported that their bone loss stopped or slowed down, with some reporting increases in their DEXA scores.
Together, these areas of research contribute to ZyCal’s effort to understand the potential of oral BMP-complexes and their role in supporting the body’s natural regenerative pathways.
A New Perspective on Bone and Joint Care
Scaffidi’s vision for regenerative medicine is practical and forward-looking. He believes the next era of bone and joint care will move beyond managing discomfort and focus increasingly on supporting the body’s ability to rebuild tissue.
Oral growth-factor complexes represent one part of this shift. By making regenerative nutrition more accessible, ZyCal aims to support biological pathways that have traditionally been associated with advanced medical procedures.
At the same time, Scaffidi views regenerative nutrition as complementary to other approaches rather than as a standalone solution. Physical therapy, biomechanical correction, weight-bearing exercise, anti-inflammatory nutrition, and, when necessary, surgical or biologic treatment can all have a role in maintaining bone and joint health.
Personalization is equally important. Different strengths and clinician-guided formulas allow regenerative nutrition to be adapted according to individual needs. This reflects the broader movement toward precision medicine, with the potential for early support for individuals at risk, targeted approaches for those experiencing degeneration, and maintenance strategies once progress has been achieved.
Extending Bone and Joint Health Span
Perhaps the most compelling element of Scaffidi’s vision is the idea of extending the bone and joint health span. He envisions a future where people can remain mobile and independent for longer, experience fewer fractures, and potentially delay or avoid joint replacement.
This perspective places mobility at the center of the conversation. Healthy bones and joints are not simply about physical comfort; they influence how people move through everyday life and how long they can maintain an active, independent lifestyle.
For ZyCal, the opportunity lies in continuing to explore how natural growth-factor complexes can support these goals. Cyplexinol® provides the foundation for this work, while the Ostinol® brand gives consumers and practitioners different ways to incorporate the ingredient into bone and joint health strategies.
At its core, ZyCal’s journey is one of scientific translation, taking principles developed through decades of orthopedic research and exploring how they can be applied in a more accessible form. Under James J. Scaffidi’s leadership, the company continues to pursue a vision in which regenerative science plays a greater role in everyday musculoskeletal health.
As the understanding of regenerative biology continues to evolve, ZyCal remains focused on the possibilities that emerge when scientific discovery, nutritional innovation, and a deeper understanding of the body’s natural processes come together. Its work represents a continued effort to move bone and joint care toward a future centered not only on supporting what already exists, but on understanding how the body can renew and rebuild.
